This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources. Find sources: "Buscaline" – news · newspapers · books · scholar · JSTOR (August 2019)

Buscaline

Clinical data
Other names	B; 3,5-Dimethoxy-4-butoxyphenethylamine; 4-Butoxy-3,5-dimethoxyphenethylamine
Routes of administration	Oral[1]
ATC code	None
Pharmacokinetic data
Duration of action	Several hours[1]
Identifiers
IUPAC name 2-(3,5-dimethoxy-4-butoxyphenyl)ethan-1-amine
CAS Number	64778-75-2 Y
PubChem CID	15102780
ChemSpider	10440102 Y
UNII	4W9CQK6FS8
ChEMBL	ChEMBL159467 Y
CompTox Dashboard (EPA)	DTXSID80568214
Chemical and physical data
Formula	C14H23NO3
Molar mass	253.342 g·mol−1
3D model (JSmol)	Interactive image
SMILES COc1cc(cc(OC)c1OCCCC)CCN
InChI InChI=1S/C14H23NO3/c1-4-5-8-18-14-12(16-2)9-11(6-7-15)10-13(14)17-3/h9-10H,4-8,15H2,1-3H3 Y Key:CHHALFOHMQNBAW-UHFFFAOYSA-N Y
(verify)

Buscaline (B), also known as 4-butoxy-3,5-dimethoxyphenethylamine, is a chemical compound prepared as a possible psychedelic drug.^[1] It is an analogue of mescaline. Buscaline was first synthesized by Alexander Shulgin.^[1] In his book PiHKAL (Phenethylamines I Have Known and Loved), the minimum dose is listed as 150 mg, and the duration as "several hours".^[1] Buscaline produced no clear hallucinogenic effects, but caused side effects like heart arrhythmia and light diarrhea.^[1] It did not cause any visuals or insights.^[1]

• Substituted mescaline analogue
• Isobuscaline

• Buscaline (B) - Isomer Design
• Buscaline - PiHKAL - Erowid
• Buscaline - PiHKAL - Isomer Design

This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it.

• v
• t
• e